Upper GI 2017

The accurate classification of MSI-GC may become clinically relevant for two reasons: (1) MSI-GCs may not require any standard adjuvant (radio-)chemotherapy in a curative setting; (2) MSI-GCs express the immune checkpoint molecules PD-L1 and PD-1 and may be considered suitable for the treatment with immune checkpoint inhibitors in the palliative setting

03/28/2017